How long after surgery would you no longer offer PMRT for a patient who had pCR after neoadjuvant chemotherapy for stage IIB HER2+ breast cancer?

The value of PMRT in HER-2 positive stage II breast cancer with pCR is debatable, to begin with, and now with 6 months or more delay, I would favor no RT.